BioCatalystWatch
TNYAWorkspace / TNYA / OverviewCompany library
Tenaya Therapeutics, Inc. logo

Tenaya Therapeutics, Inc.

Tenaya Therapeutics, Inc. (TNYA)

Website

Price
Market cap
Next catalystH2 2027 — at least one company-sponsored Phase 2 trialtn-301 · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

TN-201

PreINDP1P2P3FilingApproved
Upcoming / outlook

TN-201

Upcoming / outlook

TN-401

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

TN-201

Upcoming / outlook

TN-401

PreINDP1P2P3FilingApproved
Upcoming / outlook

TN-201

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

DWORF

PreINDP1P2P3FilingApproved
TN-301

HDAC6

TN-301

HDAC6

TN-301

HDAC6

TN-301

HDAC6

TN-301

HDAC6

TN-301

HDAC6

PreINDP1P2P3FilingApproved
TYA-018

HDAC6

PreINDP1P2P3FilingApproved
TN-501

PLN-R14del

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

TNYA PR & News

PR & News

TNYA SEC archive